Christopher Daugherty to Ethics, Medical
This is a "connection" page, showing publications Christopher Daugherty has written about Ethics, Medical.
Connection Strength
0.664
-
Informed consent, the cancer patient, and phase I clinical trials. Cancer Treat Res. 2000; 102:77-89.
Score: 0.129
-
Impact of therapeutic research on informed consent and the ethics of clinical trials: a medical oncology perspective. J Clin Oncol. 1999 May; 17(5):1601-17.
Score: 0.123
-
Ethical issues in the development of new agents. Invest New Drugs. 1999; 17(2):145-53.
Score: 0.120
-
Study of cohort-specific consent and patient control in phase I cancer trials. J Clin Oncol. 1998 Jul; 16(7):2305-12.
Score: 0.116
-
Ethical, scientific, and regulatory perspectives regarding the use of placebos in cancer clinical trials. J Clin Oncol. 2008 Mar 10; 26(8):1371-8.
Score: 0.056
-
Are we taking without giving in return? The ethics of research-related biopsies and the benefits of clinical trial participation. J Clin Oncol. 2006 Oct 20; 24(30):4793-5.
Score: 0.052
-
Examining ethical dilemmas as obstacles to hospice and palliative care for advanced cancer patients. Cancer Invest. 2004; 22(1):123-31.
Score: 0.042
-
Hope and the limits of research. Hastings Cent Rep. 1996 Sep-Oct; 26(5):20; discussion 20-2.
Score: 0.026